AI Drug Firm Insilico Debuts in Hong Kong After $293 Million IPO

AI Drug Firm Insilico Debuts in Hong Kong After 3 Million IPO



AI Drug Firm Insilico Debuts in Hong Kong After $293 Million IPO
AI-biotechnology firm Insilico Medicine Cayman TopCo is set to debut in Hong Kong on Tuesday after raising $293 million in its initial public offering.


www.bloomberg.com
#Drug #Firm #Insilico #Debuts #Hong #Kong #Million #IPO

Share: X · Facebook · LinkedIn

Leave a Reply

Your email address will not be published. Required fields are marked *